Skip to main content

Month: August 2023

Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update

MORRISVILLE, N.C., Aug. 10, 2023 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) today reported financial results for the second quarter ended June 30, 2023. The Company will host a webcast at 8:30 a.m. ET to discuss the financial results and provide a corporate update. Dr. Roger Jeffs, Liquidia’s Chief Executive Officer, said: “This quarter saw Liquidia significantly advance our mission to become the leading inhaled treprostinil provider for pulmonary hypertension patients. Achievements of note include: 1) the affirmation by the U.S. Court of Appeals for the Federal Circuit (CAFC) that all claims of the No. 9,593,066 (‘066 patent) are invalid or not infringed, 2) the filing of an amendment to add PH-ILD to the YUTREPIA label, and 3) the license of L606 from Pharmosa Biopharm to develop and commercialize...

Continue reading

Calfrac Reports Record Second-Quarter Adjusted EBITDA of $87.8 Million

CALGARY, Alberta, Aug. 10, 2023 (GLOBE NEWSWIRE) —  Calfrac Well Services Ltd. (“Calfrac” or “the Company”) (TSX: CFW) announces its financial and operating results for the three and six months ended June 30, 2023. The following press release should be read in conjunction with the management’s discussion and analysis and interim consolidated financial statements and notes thereto as at June 30, 2023. Readers should also refer to the “Forward-looking statements” legal advisory and the section regarding “Non-GAAP Measures” at the end of this press release. All financial amounts and measures are expressed in Canadian dollars unless otherwise indicated. Additional information about Calfrac is available on the SEDAR website at www.sedarplus.com, including the Company’s Annual Information Form for the year ended December 31, 2022. CEO’S...

Continue reading

McEwen Mining: Q2 2023 Results

TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) reported its second quarter (Q2) and half year (H1) results for the period ended June 30th, 2023. “The year started with operational challenges at both Gold Bar and San José. San José appears to have turned the corner and we are confident that the plan in place for Gold Bar will do the same. Fox Complex has delivered another solid quarter and we expect even better results in the second half of the year. We thank our operating teams for their hard work. The story at Los Azules keeps getting better and better! With a strong financing, an updated Preliminary Economic Assessment (PEA) showing robust economics, unparalleled partners in Rio Tinto (through Nuton) and Stellantis, and potentially game changing copper leaching technology, we could see Los...

Continue reading

PCS Edventures! Reports Unaudited Results for the First Quarter of Fiscal Year 2024

BOISE, Idaho, Aug. 10, 2023 (GLOBE NEWSWIRE) — PCS Edventures!, Inc., (PCSV) a leading provider of K-12 Science, Technology, Engineering and Mathematics (STEM) education programs and drone products, today announced unaudited results of operations for its first quarter of Fiscal Year 2024 which ended on June 30, 2023. Revenue was $2.61 million, which was up 87% from the $1.39 million in revenue generated in the same period last year. Net income was $0.86 million, compared to net income of $0.26 million for the same period last year. The Company ended the quarter with $1.04 million in cash. Michael Bledsoe, President, commented, “In terms of revenue, this was the best quarter the Company has ever had. Our initiative to go after larger customers is having broad-based success. During this quarter, we had 12 customers with orders in...

Continue reading

Vantage Drilling International Reports Second Quarter Results for 2023

HOUSTON, Aug. 10, 2023 (GLOBE NEWSWIRE) — Vantage Drilling International (“Vantage” or the “Company”) reported net income attributable to controlling interest of approximately $1.5 million, or $0.11 per diluted share, for the three months ended June 30, 2023, based on the weighted average shares outstanding, as compared to a net income attributable to controlling interest of $48.1 million, or $3.61 per diluted share, for the three months ended June 30, 2022. As of June 30, 2023, Vantage had approximately $82.4 million in cash, including $2.7 million of restricted cash, compared to $93.3 million in cash, including $19.2 million of restricted cash, at December 31, 2022. At June 30, 2023, Vantage maintained $16.9 million of cash pre-funded by our Managed Services customers to address near-term obligations during the second...

Continue reading

ZRG Acquires The Registry, an Interim Executive Solutions Firm Specializing in Higher Education

NEW YORK and BOSTON, Aug. 10, 2023 (GLOBE NEWSWIRE) — ZRG, one of the world’s rapidly growing global talent advisory firms, today announced its acquisition of The Registry, an Interim Executive Solutions firm specializing in higher education. Since 1992, The Registry has helped colleges and universities across the U.S. and abroad during times of transition with experienced and diverse interim leaders. The company’s record speaks for itself—over 1,200 placements at over 500 institutions of all types. “The Registry is the nation’s top firm providing the best-matched interim solutions to institutions of higher learning, especially colleges and universities that are going through challenging transitions,” said Larry Hartmann, CEO of ZRG. “Adding The Registry to the family of ZRG companies puts us in a leadership position in providing...

Continue reading

X4 Pharmaceuticals Reports Second-Quarter 2023 Financial Results, Provides Corporate Updates, and Reports Emerging Data from Chronic Neutropenia Clinical Program

Submission of first U.S. New Drug Application for mavorixafor in WHIM syndrome on track for early 2H 2023 Emerging data from ongoing Phase 2 trial in certain chronic neutropenic disorders show mavorixafor durably increased neutrophil counts and enabled reductions in G-CSF dosing New market research confirms significant initial target population for mavorixafor given high unmet needs within U.S. chronic neutropenia (CN) market Plans underway for initiation of Phase 3 trial in certain chronic neutropenic disorders in 1H 2024 Conference call to be hosted today at 8:30 a.m. ET BOSTON, Aug. 10, 2023 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a leader in the discovery and development of novel small-molecule therapeutics to benefit people with rare diseases of the immune system, today reported financial results for the second...

Continue reading

Interim results for the period ended June 30, 2023

Highlights and subsequent eventsGolar LNG Limited (“Golar” or “the Company”) reports Q2 2023 Net income of $7 million, and Adjusted EBITDA1 of $83 million, inclusive of $72 million of non-cash items. Total Golar Cash1 of $884 million, inclusive of $113 million of restricted cash. Executed amendments to existing Hilli debt facility that reduce debt service cost. Exercised option to acquire 2004 built LNG carrier Fuji LNG targeted for conversion to a 3.5mtpa MKII FLNG. Agreed to sell 1977 built LNG carrier Gandria for net consideration of $15 million. Signed heads of terms with Nigeria National Petroleum Corporation (“NNPC”) for joint development of gas fields using FLNG, expanding on the Memorandum of Understanding (“MOU”) signed in April 2023. FLNG Gimi conversion works 97% complete. Yard departure scheduled for September 2023. Repurchased...

Continue reading

Himax Technologies, Inc. Reports Second Quarter 2023 Financial Results; Provides Third Quarter 2023 Guidance

Q2 2023 Gross Margin Beat Guidance, Revenues and EPS at Upper End of Guidance Range Issued on May 11, 2023Company Q3 2023 Guidance: Revenues to be Flat to Decline 7.0% QoQ, Gross Margin is Expected to be 30.5% to 32.0%, Profit per diluted ADS to be around 1.5 Cents to 6.0 CentsQ2 2023 revenues were $235.0M, a decrease of 3.8% QoQ, at the upper end of guidance range of decline 9.0% to flat QoQ. Q2 GM reached 21.7%, surpassing guidance range of 20.0% to 21.0%, due to a favorable product mix Q2 2023 after-tax profit was $0.9M, or 0.5 cents per diluted ADS, compared to $14.9M, or 8.5 cents last quarter Company’s Q3 2023 revenues to be flat to decline 7.0% QoQ. GM around 30.5% to 32.0%, substantial improvement from the Q2 trough. Profit per diluted ADS to be in the range of 1.5 cents to 6.0 cents The Company sees renewed momentum in the automotive...

Continue reading

Ransomware Protection Market to Surpass 73.9 Billion by 2030 Drives Due to the Increasing Digitization of Businesses

SkyQuest projects that the ransomware protection market will attain a value of USD 73.9 billion by 2030, with a CAGR of 17.5% over the forecast period (2023-2030). The increasing digitization of businesses across various sectors has created a larger attack surface for cybercriminals to exploit in the ransomware protection market. The risk of ransomware attacks has intensified with more data and critical systems being connected online. Robust ransomware protection solutions become imperative to safeguard their valuable assets as organizations embrace digital transformation. Westford, USA, Aug. 10, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the escalating prevalence of cyber threats, including ransomware attacks, across various industries such as healthcare, BFSI (Banking, Financial Services, and Insurance), and government has...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.